1. Home
  2. SURG vs INTS Comparison

SURG vs INTS Comparison

Compare SURG & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SURG
  • INTS
  • Stock Information
  • Founded
  • SURG 2006
  • INTS 2012
  • Country
  • SURG United States
  • INTS United States
  • Employees
  • SURG N/A
  • INTS N/A
  • Industry
  • SURG Advertising
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SURG Consumer Discretionary
  • INTS Health Care
  • Exchange
  • SURG Nasdaq
  • INTS Nasdaq
  • Market Cap
  • SURG 56.5M
  • INTS 8.0M
  • IPO Year
  • SURG N/A
  • INTS 2023
  • Fundamental
  • Price
  • SURG $3.24
  • INTS $0.30
  • Analyst Decision
  • SURG Strong Buy
  • INTS Strong Buy
  • Analyst Count
  • SURG 1
  • INTS 3
  • Target Price
  • SURG $9.00
  • INTS $8.50
  • AVG Volume (30 Days)
  • SURG 108.3K
  • INTS 2.5M
  • Earning Date
  • SURG 08-12-2025
  • INTS 08-07-2025
  • Dividend Yield
  • SURG N/A
  • INTS N/A
  • EPS Growth
  • SURG N/A
  • INTS N/A
  • EPS
  • SURG N/A
  • INTS N/A
  • Revenue
  • SURG $40,029,467.00
  • INTS N/A
  • Revenue This Year
  • SURG $57.76
  • INTS N/A
  • Revenue Next Year
  • SURG $112.61
  • INTS N/A
  • P/E Ratio
  • SURG N/A
  • INTS N/A
  • Revenue Growth
  • SURG N/A
  • INTS N/A
  • 52 Week Low
  • SURG $1.05
  • INTS $0.26
  • 52 Week High
  • SURG $3.47
  • INTS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • SURG 61.40
  • INTS 36.77
  • Support Level
  • SURG $2.86
  • INTS $0.29
  • Resistance Level
  • SURG $3.31
  • INTS $0.35
  • Average True Range (ATR)
  • SURG 0.24
  • INTS 0.04
  • MACD
  • SURG 0.04
  • INTS 0.02
  • Stochastic Oscillator
  • SURG 80.49
  • INTS 35.10

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: